Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene
    Pelchovich, Gidi
    Zhuravlev, Alina
    Gophna, Uri
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (02) : 129 - 132
  • [22] Targeting NF-κB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells
    Zhu, Shan
    Liu, Jiao
    Kang, Rui
    Yang, Minghua
    Tang, Daolin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 562 : 55 - 61
  • [23] Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting
    Thi Phuong Anh Tran
    Duc Duy Vo
    Di Giorgio, Audrey
    Duca, Maria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5334 - 5344
  • [24] Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
    Bosc, Claudie
    Saland, Estelle
    Bousard, Aurelie
    Gadaud, Noemie
    Sabatier, Marie
    Cognet, Guillaume
    Farge, Thomas
    Boet, Emeline
    Gotanegre, Mathilde
    Aroua, Nesrine
    Mouchel, Pierre-Luc
    Polley, Nathaniel
    Larrue, Clement
    Kaphan, Eleonore
    Picard, Muriel
    Sahal, Ambrine
    Jarrou, Latifa
    Tosolini, Marie
    Rambow, Florian
    Cabon, Florence
    Nicot, Nathalie
    Poillet-Perez, Laura
    Wang, Yujue
    Su, Xiaoyang
    Fovez, Quentin
    Kluza, Jerome
    Arguello, Rafael Jose
    Mazzotti, Celine
    Avet-Loiseau, Herve
    Vergez, Francois
    Tamburini, Jerome
    Fournie, Jean-Jacques
    Tiong, Ing S.
    Wei, Andrew H.
    Kaoma, Tony
    Marine, Jean-Christophe
    Recher, Christian
    Stuani, Lucille
    Joffre, Carine
    Sarry, Jean-Emmanuel
    NATURE CANCER, 2021, 2 (11) : 1204 - +
  • [25] Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations
    Shahswar, Rabia
    Ganser, Arnold
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 723 - 739
  • [26] Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience
    Trabal, Adriana
    Gibson, Amber
    He, Jiasen
    McCall, David
    Roth, Michael
    Nunez, Cesar
    Garcia, Miriam
    Buzbee, Meredith
    Toepfer, Laurie
    Bidikian, Aram
    Daver, Naval
    Kadia, Tapan
    Short, Nicholas J.
    Issa, Ghayas C.
    Ravandi, Farhad
    DiNardo, Courtney D.
    Bravo, Guillermo Montalban
    Garces, Sofia
    Marcogliese, Andrea
    Paek, Hana
    Dreyer, Zoann
    Brackett, Julienne
    Redell, Michele
    Yi, Joanna
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Stevens, Alexandra
    Cuglievan, Branko
    CANCERS, 2023, 15 (07)
  • [27] Evaluating venetoclax and its potential in treatment-naive acute myeloid leukemia
    Knight, Tristan
    Edwards, Holly
    Taub, Jeffrey W.
    Ge, Yubin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3197 - 3213
  • [28] Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients
    Chatzikalil, Elena
    Roka, Kleoniki
    Diamantopoulos, Panagiotis T.
    Rigatou, Efthymia
    Avgerinou, Georgia
    Kattamis, Antonis
    Solomou, Elena E.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [29] Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance
    Uddin, Rehan
    Darwish, Noureldian H. E.
    Mousa, Shaker A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (09)
  • [30] Combined venetoclax and alvocidib in acute myeloid leukemia
    Bogenberger, James
    Whatcott, Clifford
    Hansen, Nanna
    Delman, Devora
    Shi, Chang-Xin
    Kim, Wontak
    Haws, Hillary
    Soh, Katherine
    Lee, Ye Sol
    Peterson, Peter
    Siddiqui-Jain, Adam
    Weitman, Steven
    Stewart, Keith
    Bearss, David
    Mesa, Ruben
    Warner, Steven
    Tibes, Raoul
    ONCOTARGET, 2017, 8 (63): : 107206 - 107222
12345